Aliases & Classifications for Fainting

MalaCards integrated aliases for Fainting:

Name: Fainting 50 40

Summaries for Fainting

NINDS : 50 Syncope is a medical term used to describe a temporary loss of consciousness due to the sudden decline of blood flow to the brain. Syncope is commonly called fainting or “passing out.” If an individual is about to faint, he or she will feel dizzy, lightheaded, or nauseous and their field of vision may “white out” or “black out.”  The skin may be cold and clammy.  The person drops to the floor as he or she loses consciousness.  After fainting, an individual may be unconscious for a minute or two, but will revive and slowly return to normal.  Syncope can occur in otherwise healthy people and affects all age groups, but occurs more often in the elderly.  There are several types of syncope.  Vasovagal syncope usually has an easily identified triggering event such as emotional stress, trauma, pain, the sight of blood, or prolonged standing.  Carotid sinus syncope happens because of constriction of the carotid artery in the neck and can occur after turning the head, while shaving, or when wearing a tight collar.  Situational syncope happens during urination, defecation, coughing, or as a result of gastrointestinal stimulation.  Syncope can also be a symptom of heart disease or abnormalities that create an uneven heart rate or rhythm that temporarily affect blood volume and its distribution in the body.  Syncope isn’t normally a primary sign of a neurological disorder, but it may indicate an increased risk for neurologic disorders such as Parkinson’s disease, postural orthostatic tachycardia syndrome (POTS), diabetic neuropathy, and other types of neuropathy.  Certain classes of drugs are associated with an increased risk of syncope, including diuretics, calcium antagonists, ACE inhibitors, nitrates, antipsychotics, antihistamines, levodopa, narcotics, and alcohol.

MalaCards based summary : Fainting is related to atrial fibrillation and myocardial infarction. An important gene associated with Fainting is KCNH2 (Potassium Voltage-Gated Channel Subfamily H Member 2), and among its related pathways/superpathways are Formation of Fibrin Clot (Clotting Cascade) and Complement and coagulation cascades. The drugs Amiodarone and Ranolazine have been mentioned in the context of this disorder. Affiliated tissues include heart, brain and skin.

MedlinePlus : 40 Fainting is a temporary loss of consciousness. If you're about to faint, you'll feel dizzy, lightheaded, or nauseous. Your field of vision may "white out" or "black out." Your skin may be cold and clammy. You lose muscle control at the same time, and may fall down. Fainting usually happens when your blood pressure drops suddenly, causing a decrease in blood flow to your brain. It is more common in older people. Some causes of fainting include Heat or dehydration Emotional distress Standing up too quickly Certain medicines Drop in blood sugar Heart problems When someone faints, make sure that the airway is clear and check for breathing. The person should stay lying down for 10-15 minutes. Most people recover completely. Fainting is usually nothing to worry about, but it can sometimes be a sign of a serious problem. If you faint, it's important to see your health care provider and find out why it happened.

Wikipedia : 72 Syncope, also known as fainting, is a loss of consciousness and muscle strength characterized by a fast... more...

Related Diseases for Fainting

Diseases related to Fainting via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 108)
# Related Disease Score Top Affiliating Genes
1 atrial fibrillation 30.1 KCNH2 VWF
2 myocardial infarction 29.9 CHKB F8 VWF
3 syncope 11.3
4 long qt syndrome 11.1
5 postural orthostatic tachycardia syndrome 11.0
6 jervell and lange-nielsen syndrome 1 11.0
7 chronic orthostatic intolerance 11.0
8 aortic valve disease 2 10.9
9 myotonia congenita, autosomal recessive 10.9
10 myotonia congenita 10.9
11 catecholaminergic polymorphic ventricular tachycardia 10.8
12 osteogenesis imperfecta, type xiii 10.8
13 hypertrophic cardiomyopathy 10.8
14 long qt syndrome 1 10.8
15 brugada syndrome 10.8
16 familial atrial fibrillation 10.8
17 ectopic pregnancy 10.8
18 long qt syndrome 3 10.7
19 ovarian cyst 10.7
20 vibratory urticaria 10.7
21 brugada syndrome 9 10.7
22 multiple system atrophy 1 10.7
23 amyloidosis 10.7
24 andersen cardiodysrhythmic periodic paralysis 10.7
25 syncope, familial vasovagal 10.7
26 dilated cardiomyopathy 10.7
27 autoimmune autonomic ganglionopathy 10.7
28 pulmonary hypertension, primary, 1 10.7
29 hyperinsulinemic hypoglycemia, familial, 7 10.7
30 patent foramen ovale 10.7
31 familial progressive cardiac conduction defect 10.7
32 brugada syndrome 2 10.7
33 cardiomyopathy, familial hypertrophic, 1 10.7
34 brugada syndrome 3 10.7
35 hereditary alpha tryptasemia syndrome 10.7
36 brugada syndrome 4 10.7
37 brugada syndrome 5 10.7
38 arrhythmogenic right ventricular cardiomyopathy 10.7
39 peters-plus syndrome 10.7
40 brugada syndrome 6 10.7
41 atrial fibrillation and stroke 10.7
42 brugada syndrome 7 10.7
43 brugada syndrome 8 10.7
44 brugada syndrome 1 10.7
45 long qt syndrome 2 10.7
46 multiple system atrophy with orthostatic hypotension 10.7
47 cerebritis 10.0
48 ventricular fibrillation, paroxysmal familial, 1 10.0 CHKB KCNH2
49 compartment syndrome 10.0 CHKB F8
50 episodic pain syndrome, familial, 1 9.9

Graphical network of the top 20 diseases related to Fainting:



Diseases related to Fainting

Symptoms & Phenotypes for Fainting

Drugs & Therapeutics for Fainting

Drugs for Fainting (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 240)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Amiodarone Approved, Investigational Phase 4,Phase 3 1951-25-3 2157
2
Ranolazine Approved, Investigational Phase 4,Phase 2 95635-55-5, 142387-99-3 56959
3
Testosterone Approved, Investigational Phase 4 58-22-0 6013
4
Losartan Approved Phase 4 114798-26-4 3961
5
Hydrochlorothiazide Approved, Vet_approved Phase 4,Phase 3 58-93-5 3639
6
Amlodipine Approved Phase 4 88150-42-9 2162
7
Bisoprolol Approved Phase 4,Phase 3 66722-44-9 2405
8
Metoprolol Approved, Investigational Phase 4 51384-51-1, 37350-58-6 4171
9
Propranolol Approved, Investigational Phase 4,Phase 2 525-66-6 4946
10
Angiotensin II Approved, Investigational Phase 4,Phase 3 68521-88-0, 4474-91-3, 11128-99-7 172198 65143
11
Midodrine Approved Phase 4 42794-76-3, 133163-28-7 4195
12
Fludrocortisone Approved, Investigational Phase 4 127-31-1 31378
13
Treprostinil Approved, Investigational Phase 4 81846-19-7 6918140 54786
14
Epoprostenol Approved Phase 4 61849-14-7, 35121-78-9 5282411 5280427
15
Methyltestosterone Approved Phase 4 58-18-4 6010
16
Atenolol Approved Phase 4 29122-68-7 2249
17
Donepezil Approved Phase 4 120014-06-4 3152
18 Adrenergic Agents Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1
19 Adrenergic Agonists Phase 4,Phase 1,Phase 2,Early Phase 1
20 Adrenergic alpha-Agonists Phase 4,Phase 1,Phase 2,Early Phase 1
21 Sodium Channel Blockers Phase 4,Phase 3,Phase 2
22 Neurotransmitter Agents Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1
23 Cytochrome P-450 CYP1A2 Inhibitors Phase 4,Phase 3
24 Cytochrome P-450 CYP2C9 Inhibitors Phase 4,Phase 3
25 Cytochrome P-450 CYP2D6 Inhibitors Phase 4,Phase 3
26 Cytochrome P-450 CYP3A Inhibitors Phase 4,Phase 3
27 Vasoconstrictor Agents Phase 4,Phase 1,Phase 2,Early Phase 1
28 Cytochrome P-450 Enzyme Inhibitors Phase 4,Phase 3
29 Vasodilator Agents Phase 4,Phase 3,Phase 2
30 Diuretics, Potassium Sparing Phase 4,Phase 3,Phase 2
31 Peripheral Nervous System Agents Phase 4,Phase 3,Phase 1,Phase 2,Early Phase 1
32 Anti-Arrhythmia Agents Phase 4,Phase 3,Phase 2
33 Potassium Channel Blockers Phase 4,Phase 3
34 Anti-Inflammatory Agents Phase 4,Phase 1,Phase 2
35 Autonomic Agents Phase 4,Phase 3,Phase 1,Phase 2,Early Phase 1
36 Tezosentan Phase 4
37 Testosterone undecanoate Phase 4
38
Testosterone enanthate Phase 4 315-37-7 9416
39 calcium channel blockers Phase 4
40 diuretics Phase 4,Phase 3,Phase 1,Phase 2
41 Adrenergic Antagonists Phase 4,Phase 3,Phase 2
42 Adrenergic beta-1 Receptor Antagonists Phase 4,Phase 3
43 Sodium Chloride Symporter Inhibitors Phase 4,Phase 3
44 Adrenergic beta-Antagonists Phase 4,Phase 3,Phase 2,Phase 1
45 Sympatholytics Phase 4,Phase 3
46 Natriuretic Agents Phase 4,Phase 3,Phase 1,Phase 2
47 Testosterone 17 beta-cypionate Phase 4
48 Anabolic Agents Phase 4
49 Androgens Phase 4
50 Hormone Antagonists Phase 4

Interventional clinical trials:

(show top 50) (show all 298)

# Name Status NCT ID Phase Drugs
1 Closed Loop Stimulation for Neuromediated Syncope (SPAIN Study) Unknown status NCT01621464 Phase 4
2 Safety of Amiodarone and Ranolazine Together in Patients With Angina Unknown status NCT01558830 Phase 4 ranolazine;placebo
3 Clinical Trial for the Prevention of Vasovagal Syncope Completed NCT00118482 Phase 4 fludrocortisone acetate
4 ISSUE3: International Study on Syncope of Uncertain Etiology 3 Completed NCT00359203 Phase 4
5 Propranolol to Treat Fainting Due to Sympathoadrenal Imbalance Completed NCT00060866 Phase 4 Propranolol
6 ELIAS: Early Loop-Recorder in Suspected Arrhythmogenic Syncope Completed NCT00170261 Phase 4
7 Comparision of Blood Pressure Variability Between Amlodipine and Losartan Completed NCT01964079 Phase 4 Amlodipine;Losartan
8 Tilt-Table Study of the Clinical Efficacy of Midodrine in Symptomatic Orthostatic Hypotension Completed NCT01518946 Phase 4 Midodrine HCl;Placebo
9 Multicenter Automatic Defibrillator Implantation Trial - Reduce Inappropriate Therapy Completed NCT00947310 Phase 4
10 Physiologic Evaluation of Anomalous Right Coronary Artery Stenosis Completed NCT01133054 Phase 4
11 Programming Implantable Cardioverter Defibrillators in Patients With Primary Prevention Indication Completed NCT00743522 Phase 4
12 A Comparison of Polyglactin 910 and Chromic Gut Suture in the Closure of Punch Biopsy Sites Completed NCT01722994 Phase 4
13 Effects of Testosterone on Myocardial Repolarization Completed NCT03126656 Phase 4 Testosterone Undecanoate
14 Safety, Efficacy and Treatment Satisfaction in Patients With PAH Rapidly Switched From Epoprostenol to Remodulin Completed NCT00373360 Phase 4 treprostinil sodium
15 Evaluation of PCLs Using Three EUS-FNA Needles Completed NCT01711294 Phase 4
16 Assessment of Midodrine in the Prevention of Vasovagal Syncope: The Prevention of Syncope Trial IV Recruiting NCT01456481 Phase 4 midodrine hydrochloride;matching placebo
17 Assessment of Metoprolol in the Prevention of Vasovagal Syncope in Aging Subjects Recruiting NCT02123056 Phase 4 Metoprolol;Matching Placebo
18 Combining Donepezil With Perceptual Learning in Normal and Amblyopic Human The Effect of Donepezil on Perceptual Learning in Adult Amblyopia Recruiting NCT03109314 Phase 4 Donepezil
19 Evaluation of Decreased Usage of Betablockers After Myocardial Infarction in the SWEDEHEART Registry (REDUCE-SWEDEHEART) Recruiting NCT03278509 Phase 4 Metoprolol Succinate;Bisoprolol
20 Syncope: Pacing or Recording in the Later Years Active, not recruiting NCT01423994 Phase 4
21 International Study on Syncope of Uncertain Etiology Terminated NCT00120094 Phase 4
22 A Phase IV Study in Subjects With Neurogenic Orthostatic Hypotension Terminated NCT00046163 Phase 4 midodrine hydrochloride (ProAmatine®)
23 Rapid Switch From Flolan to Remodulin in the Outpatient Clinic Terminated NCT00643604 Phase 4 treprostinil sodium
24 Safety, Efficacy, and Treatment Satisfaction Switching From Flolan to Remodulin Using the Crono Five Ambulatory Pump in Patients With PAH Terminated NCT00439946 Phase 4 treprostinil
25 Lactobacillus Reuteri in Treatment of Functional Abdominal Pain and Chronic Constipation in Children Unknown status NCT01587846 Phase 3
26 Stop Vasodepressor Drugs in Reflex Syncope Completed NCT02137278 Phase 3 Vasoactive drug therapies
27 A Two Part Study (306A/306B) to Assess Droxidopa in Treatment of NOH in Patients With Parkinson's Disease Completed NCT01176240 Phase 3 Droxidopa
28 Clinical Study of Droxidopa in Patients With Neurogenic Orthostatic Hypotension (NOH) Completed NCT00633880 Phase 3 Placebo;Droxidopa
29 Effects of PTH Replacement on Bone in Hypoparathyroidism Completed NCT00395538 Phase 3 PTH 1-34
30 Ablation of Clinical Ventricular Tachycardia Versus Addition of Substrate Ablation on the Long Term Success Rate of VT Ablation Completed NCT01045668 Phase 3
31 Irbesartan/Hydrochlorothiazide (HCTZ) Combination Therapy for Patients With Moderate Hypertension Completed NCT00095550 Phase 3 Irbesartan/HCTZ;Irbesartan monotherapy;HCTZ monotherapy
32 Irbesartan/Hydrochlorothiazide (HCTZ) Combination Therapy as First Line Treatment for Severe Hypertension Completed NCT00095394 Phase 3 Irbesartan/HCTZ;Irbesartan monotherapy
33 Induction With Foley OR Misoprostol (INFORM) Study Completed NCT01801410 Phase 3 Misoprostol
34 Safety/Efficacy Study Comparing the Misoprostol Vaginal Insert to Cervidil for Cervical Ripening and Induction of Labor Completed NCT00308711 Phase 3 Misoprostol vaginal insert 100 mcg;Misoprostol vaginal insert 50 mcg;Dinoprostone vaginal insert (Cervidil)
35 Cooperative Studies Program #563 - Prazosin and Combat Trauma PTSD Completed NCT00532493 Phase 3 prazosin
36 Chagas Cardiomyopathy Bisoprolol Intervention Study: Charity Completed NCT00323973 Phase 3 Bisoprolol
37 A Clinical Study for Patients With Neurogenic Orthostatic Hypotension (NOH) Using Droxidopa Completed NCT00782340 Phase 3 Placebo;Droxidopa
38 Open-Label Clinical Study of Droxidopa in Patients With Neurogenic Orthostatic Hypotension (NOH) Completed NCT00738062 Phase 3 Droxidopa;Placebo
39 Efficacy of Transcatheter Ablation Using Anatomic Approach of Ganglionated Plexi Located in the Right Atrium to Prevent Neuromediated Cardioinhibitory Syncope Recruiting NCT01814228 Phase 3
40 Perioperative Antibiotic Therapy to Prevent Cardiac Implantable Electronic Device Infections. Recruiting NCT02809131 Phase 3 polymixin/bacitracin;cephalexin, or levofloxacin, or clindamycin;Saline
41 Traumatic Optic Neuropathy Treatment Trial 2 Recruiting NCT03308448 Phase 3 Recombinant human erythropoietin
42 Efficacy of Implantable Defibrillator Therapy After a Myocardial Infarction Recruiting NCT00673842 Phase 3
43 A Study to Systematically Assess the Efficacy and Safety of Intravenous Albumin Infusions in Severe POTS Not yet recruiting NCT03365414 Phase 3 Normal Saline 0.9% Infusion Solution Bag
44 Ballooned Intercostal Drain Trial Not yet recruiting NCT03000504 Phase 3
45 Effect of Chronic Oral Hydration in Patients With Recurrent Unexplained Syncope Terminated NCT00143754 Phase 3
46 A Clinical Study of Patients With Symptomatic NOH to Assess Sustained Effects of Droxidopa Therapy Terminated NCT01927055 Phase 3 Droxidopa;Placebo
47 Hydroquinidine Versus Placebo in Patients With Brugada Syndrome Terminated NCT00927732 Phase 3 hydroquinidine;placebo (sugar)
48 Differential Effect of Silodosin Versus Tamsulosin on Stone Clearance After Extra-corporeal Shock Wave Lithotripsy Withdrawn NCT01560091 Phase 3 silodosin;Tamsulosin
49 Evaluate the Noninferiority of Medicines Treating Uninfected Pressure Ulcers. Withdrawn NCT02004626 Phase 3 Collagenase;Kollagenase
50 Trial Comparing Ablation With Medical Therapy in Patients With Ventricular Tachycardia Withdrawn NCT01798277 Phase 3 Medical therapy (sotalol or amiodarone)

Search NIH Clinical Center for Fainting

Genetic Tests for Fainting

Anatomical Context for Fainting

MalaCards organs/tissues related to Fainting:

38
Heart, Brain, Skin, Testes, Thyroid, Liver, Colon

Publications for Fainting

Articles related to Fainting:

(show top 50) (show all 205)
# Title Authors Year
1
Fainting episode in a pacemaker dependent patient with two implanted devices. Too much of a good thing! ( 28476432 )
2017
2
Fainting: What You Should Know. ( 28290650 )
2017
3
Case report: fainting during acupuncture stimulation at acupuncture point LI4. ( 28274225 )
2017
4
Comparison of Specific Fainting Characteristics Between Youth With Tilt-Induced Psychogenic Nonsyncopal Collapse Versus Reflex Syncope. ( 28236458 )
2017
5
Mass fainting in garment factories in Cambodia. ( 28398195 )
2017
6
Sympathetic and parasympathetic cardiac responses to phobia-relevant and disgust-specific emotion provocation in blood-injection-injury phobia with and without fainting history. ( 28667690 )
2017
7
Fainting Fanconi syndrome clarified by proxy: a case report. ( 28693455 )
2017
8
Syncope: Not for the faint hearted. ( 27189260 )
2016
9
Clinical Pearls - how my patients taught me: The fainting lark symptom. ( 27822381 )
2016
10
An Experimental Model of Vasovagal Syncope Induces Cerebral Hypoperfusion and Fainting-Like Behavior in Awake Rats. ( 27658057 )
2016
11
Syncope (Fainting). ( 27142609 )
2016
12
Fainting After Chest Pain. ( 27122877 )
2015
13
Fainting Starting Parenteral Nutrition. ( 25853719 )
2015
14
Fifteen-minute consultation on limiting investigations in the fainting child. ( 26201347 )
2015
15
Prognosis of glioblastoma with faint MGMT methylation-specific PCR product. ( 25575938 )
2015
16
Role of sympathetic nerve activity in the process of fainting. ( 25309444 )
2014
17
Fainting (vasovagal syncope): case reports. ( 25198333 )
2014
18
Giving blood donors something to drink before donation can prevent fainting symptoms: is there a physiological or psychological reason? ( 25130724 )
2014
19
Fainting as an unusual presentation of a large inferior vena cava leiomyosarcoma. ( 24837084 )
2014
20
A mobile system for real-time context-aware monitoring of patients' health and fainting. ( 25946886 )
2014
21
Purinergic profile of fainting divers is different from patients with vasovagal syncope. ( 24798778 )
2014
22
Alteration in cardiovascular and postural control relationship in non-fainting elderly individuals. ( 25570750 )
2014
23
57-year-old man with flushing and fainting. ( 23639502 )
2013
24
Skin infiltration of nodal peripheral t-cell lymphoma-not otherwise specified identified by skin biopsy of faint eruptions. ( 23723524 )
2013
25
Malignant cardioinhibitory vasovagal syncope - an uncommon cardiovascular complication of Roux-en-Y gastric bypass surgery: the fainting syndrome! ( 23063207 )
2013
26
External pneumatic compression device prevents fainting in standing weight-bearing MRI: a cohort study. ( 23857423 )
2013
27
Long-Term Stability of Uveitis with Faint Anterior Chamber Flare Treated with Once-Daily Topical Ophthalmic Betamethasone. ( 24114448 )
2013
28
Small left atrial volume is an independent predictor for fainting during head-up tilt test: the impact of intracardiac volume reserve in vasovagal syncope. ( 22000265 )
2013
29
The relation between disgust-sensitivity, blood-injection-injury fears and vasovagal symptoms in blood donors: disgust sensitivity cannot explain fainting or blood donation-related symptoms. ( 21906532 )
2012
30
A pacemaker to prevent fainting. If your heart rate slows, a device can stop you from dropping. ( 23101130 )
2012
31
A 40-year-old man with recurrent fainting, hypotension, lower limb edema and oliguria with body weight gain and secondary erythrocytosis. ( 21948352 )
2012
32
What's at the heart of fainting? Most fainting is not related to abnormal heart rhythms. ( 22872881 )
2012
33
Case 2: 'I feel faint': An adolescent with recurrent dizziness and syncope. ( 23730166 )
2012
34
Fainting attacks in children. ( 21695380 )
2012
35
Does disgust increase parasympathetic activation in individuals with a history of fainting? A psychophysiological analysis of disgust stimuli with and without blood-injection-injury association. ( 23023164 )
2012
36
Sensitivity of MDM2 amplification and unexpected multiple faint alphoid 12 (alpha 12 satellite sequences) signals in atypical lipomatous tumor. ( 22699518 )
2012
37
Factors associated with fainting: before, during and after whole blood donation. ( 21535440 )
2011
38
Episode of fainting and tetany after an evaluation technique of the upper cervical region: a case report. ( 20724209 )
2011
39
Fainting, swooning, and syncope. ( 22132356 )
2011
40
Physiologic strategies to prevent fainting responses during or after whole blood donation. ( 21645008 )
2011
41
Clinical reasoning: a teenage girl with excessive daytime sleepiness, "fainting spells," and dream mentations. ( 20498429 )
2010
42
Correlations between urinary excretion of catecholamines and electrocardiographic parameters of vagal hyperreactivity in infants with fainting spells. Implication of sympathetic hypotonia? ( 21074121 )
2010
43
A 46-year-old woman with chin pain and a fainting spell. ( 20391493 )
2010
44
To avoid fainting: cross the legs and not the fingers. ( 20106794 )
2010
45
Pituitary adenomas that show a faint GH-immunoreactivity but lack fibrous body: Pit-1 adenoma with endocrinologically low activity. ( 20111911 )
2010
46
Fainting with HIV. ( 20800149 )
2010
47
A 37-year-old man with recurrent fainting: a short communication. ( 20348158 )
2010
48
Fainting, emancipation and the 'weak and sensitive' sex. ( 19567743 )
2009
49
Diagnostic tests for fainting found expensive, ineffective. The cheapest test for syncope--a postural blood pressure recording--may yield the most answers. ( 20120509 )
2009
50
Increased phase synchronization and decreased cerebral autoregulation during fainting in the young. ( 19820196 )
2009

Variations for Fainting

Expression for Fainting

Search GEO for disease gene expression data for Fainting.

Pathways for Fainting

GO Terms for Fainting

Cellular components related to Fainting according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 platelet alpha granule lumen GO:0031093 8.62 F8 VWF

Biological processes related to Fainting according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 blood coagulation GO:0007596 9.32 F8 VWF
2 platelet degranulation GO:0002576 9.26 F8 VWF
3 platelet activation GO:0030168 9.16 F8 VWF
4 hemostasis GO:0007599 8.96 F8 VWF
5 blood coagulation, intrinsic pathway GO:0007597 8.62 F8 VWF

Sources for Fainting

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
16 ExPASy
18 FMA
27 GO
28 GTR
29 HGMD
30 HMDB
31 HPO
32 ICD10
33 ICD10 via Orphanet
34 ICD9CM
35 IUPHAR
36 KEGG
37 LifeMap
39 MedGen
41 MeSH
42 MESH via Orphanet
43 MGI
45 NCI
46 NCIt
47 NDF-RT
50 NINDS
51 Novoseek
53 OMIM
54 OMIM via Orphanet
58 PubMed
60 QIAGEN
65 SNOMED-CT via HPO
66 SNOMED-CT via Orphanet
67 TGDB
68 Tocris
69 UMLS
70 UMLS via Orphanet
Content
Loading form....